| British Society of Gastroenterology guidelines on the management of irritable bowel syndrome DH Vasant, PA Paine, CJ Black, LA Houghton, HA Everitt, M Corsetti, ... Gut 70 (7), 1214-1240, 2021 | 333 | 2021 |
| Mindfulness, self-compassion and psychological inflexibility mediate the effects of a mindfulness-based intervention in a sample of oncology nurses J Duarte, J Pinto-Gouveia Journal of Contextual Behavioral Science 6 (2), 125-133, 2017 | 117 | 2017 |
| British Society of Gastroenterology guidelines on the management of functional dyspepsia CJ Black, PA Paine, A Agrawal, I Aziz, MP Eugenicos, LA Houghton, ... Gut 71 (9), 1697-1723, 2022 | 86 | 2022 |
| Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree TD Miller, AP Jackson, R Barresi, CM Smart, M Eugenicos, D Summers, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (5), 583-584, 2009 | 56 | 2009 |
| Pilot study of acceptance and commitment therapy for irritable bowel syndrome: A preliminary analysis of treatment outcomes and processes of change NB Ferreira, D Gillanders, PG Morris, M Eugenicos Clinical Psychologist 22 (2), 241-250, 2018 | 54 | 2018 |
| Measuring acceptance in irritable bowel syndrome: Preliminary validation of an adapted scale and construct utility NB Ferreira, MP Eugenicos, PG Morris, DT Gillanders Quality of Life Research 22, 1761-1766, 2013 | 45 | 2013 |
| Using acceptance and commitment therapy in irritable bowel syndrome N Bravo Ferreira, M Eugenicos, P Graham Morris, D Gillanders Gastrointestinal Nursing 9 (9), 28-35, 2011 | 31 | 2011 |
| An implementation trial of ACT-based bibliotherapy for irritable bowel syndrome D Gillanders, NB Ferreira, E Angioni, SA Carvalho, MP Eugenicos Journal of Contextual Behavioral Science 6 (2), 172-177, 2017 | 23 | 2017 |
| Scan-negative cauda equina syndrome: a prospective cohort study I Hoeritzauer, A Carson, P Statham, JN Panicker, V Granitsiotis, ... Neurology 96 (3), e433-e447, 2021 | 22 | 2021 |
| Randomised, placebo‐controlled trial and meta‐analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: the TRITON trial D Gunn, R Topan, L Barnard, R Fried, I Holloway, R Brindle, M Corsetti, ... Alimentary Pharmacology & Therapeutics 57 (11), 1258-1271, 2023 | 18 | 2023 |
| Psychological factors associated with inflammatory bowel disease MP Eugenicos, NB Ferreira British Medical Bulletin 138 (1), 16-28, 2021 | 18 | 2021 |
| Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial D Gunn, R Fried, R Lalani, A Farrin, I Holloway, T Morris, C Olivier, ... Trials 20, 1-12, 2019 | 16 | 2019 |
| The prevalence of faecal incontinence in myotonic dystrophy type 1 RKH Petty, MP Eugenicos, MJ Hamilton, ME Farrugia, Y Robb, ... Neuromuscular Disorders 29 (7), 562-566, 2019 | 12 | 2019 |
| UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation Y Yiannakou, A Agrawal, PB Allen, N Arebi, SR Brown, MP Eugenicos, ... Therapeutic Advances in Gastroenterology 11, 1756284818798791, 2018 | 10 | 2018 |
| The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global … H Jaafari, LA Houghton, RM West, A Agrawal, I Aziz, CJ Black, M Corsetti, ... Neurogastroenterology & Motility 35 (6), e14574, 2023 | 7 | 2023 |
| OC-066 Economic and quality-of-life burden of moderate-to-severe irritable bowel syndrome with constipation (ibs-c) in the uk: the ibis-c study Y Yiannakou, M Eugenicos, DS Sanders, A Emmanuel, P Whorwell, F Butt, ... Gut 64 (Suppl 1), A33-A34, 2015 | 2 | 2015 |
| The role of illness perceptions and acceptance in irritable bowel syndrome (IBS) outcomes N Ferreira, P Morris, M Eugenicos, D Gillanders Psychology & Health 25, 33-33, 2010 | 2 | 2010 |
| PWE-251 Diagnosis and management of moderate-to-severe irritable bowel syndrome with constipation (IBS-C) in the UK: the IBIS-C study Y Yiannakou, M Eugenicos, DS Sanders, A Emmanuel, P Whorwell, F Butt, ... Gut 64 (Suppl 1), A323-A323, 2015 | 1 | 2015 |
| Clinical trial results D Gunn, R Topan, R Fried, I Holloway, R Brindle, S Hartley, L Barnard, ... Ondansetron for irritable bowel syndrome with diarrhoea: randomised …, 2023 | | 2023 |
| O54 The national prevalence of disorders of gut-brain interaction in the United Kingdom compared to their worldwide prevalence H Jaafari, L Houghton, R West, I Aziz, C Black, M Corsetti, P Paine, ... Gut 72 (Suppl 2), A31-A31, 2023 | | 2023 |
